EACCME participant's evaluation form

The XV EBMWG International Bone Marrow Course and

Please fill in the form below to receive your CME certificate. This will be sent out to you by email after the survey has closed.

Please note that if you are using gmail our email with your certificate might end up in your spam folder.

Question Title

* 1. How useful for your professional activity did you find this event?

Extremely useful

Useful

Fairly useful

Not useful

If this activity was not useful, please explain why:

Question Title

* 2. What was your overall impression of this event?

	Excellent	Good	Fairly good	Poor	Very poor
Programme	Programme Excellent	Programme Good	Programme Fairly good	Programme Poor	Programme Very poor
Organisation	Organisation Excellent	Organisation Good	Organisation Fairly good	Organisation Poor	Organisation Very poor

What was the best and worst aspect of this event?

Question Title

* 3. Did the event fulfil your educational goals and expected learning outcomes?

Very much

Somewhat

Not much

Not at all

Undecided

Question Title

* 4. Was the presented information well balanced and consistently supported by a valid scientific evidence base?

Very much

Somewhat

Not much

Not at all

Undecided

Question Title

* 5. How useful to you personally was each session?

	Extremely useful	Useful	Fairly useful	Not useful	Undecided/DNA
The normal bone marrow and reactive changes	The normal bone marrow and reactive changes Extremely useful	The normal bone marrow and reactive changes Useful	The normal bone marrow and reactive changes Fairly useful	The normal bone marrow and reactive changes Not useful	The normal bone marrow and reactive changes Undecided/DNA
Diagnostic relevance of immunohistochemistry for bone marrow diagnostics	Diagnostic relevance of immunohistochemistry for bone marrow diagnostics Extremely useful	Diagnostic relevance of immunohistochemistry for bone marrow diagnostics Useful	Diagnostic relevance of immunohistochemistry for bone marrow diagnostics Fairly useful	Diagnostic relevance of immunohistochemistry for bone marrow diagnostics Not useful	Diagnostic relevance of immunohistochemistry for bone marrow diagnostics Undecided/DNA
Diagnostic relevance of flow cytometry for bone marrow diagnostics	Diagnostic relevance of flow cytometry for bone marrow diagnostics Extremely useful	Diagnostic relevance of flow cytometry for bone marrow diagnostics Useful	Diagnostic relevance of flow cytometry for bone marrow diagnostics Fairly useful	Diagnostic relevance of flow cytometry for bone marrow diagnostics Not useful	Diagnostic relevance of flow cytometry for bone marrow diagnostics Undecided/DNA
Basic molecular diagnostics of bone marrow neoplasms	Basic molecular diagnostics of bone marrow neoplasms Extremely useful	Basic molecular diagnostics of bone marrow neoplasms Useful	Basic molecular diagnostics of bone marrow neoplasms Fairly useful	Basic molecular diagnostics of bone marrow neoplasms Not useful	Basic molecular diagnostics of bone marrow neoplasms Undecided/DNA
Practical approach to the integrative diagnosis of B-cell lymphomas and plasma cell disorders in the bone marrow	Practical approach to the integrative diagnosis of B-cell lymphomas and plasma cell disorders in the bone marrow Extremely useful	Practical approach to the integrative diagnosis of B-cell lymphomas and plasma cell disorders in the bone marrow Useful	Practical approach to the integrative diagnosis of B-cell lymphomas and plasma cell disorders in the bone marrow Fairly useful	Practical approach to the integrative diagnosis of B-cell lymphomas and plasma cell disorders in the bone marrow Not useful	Practical approach to the integrative diagnosis of B-cell lymphomas and plasma cell disorders in the bone marrow Undecided/DNA
Practical approach to the integrative diagnosis and classification of myelodysplastic syndromes	Practical approach to the integrative diagnosis and classification of myelodysplastic syndromes Extremely useful	Practical approach to the integrative diagnosis and classification of myelodysplastic syndromes Useful	Practical approach to the integrative diagnosis and classification of myelodysplastic syndromes Fairly useful	Practical approach to the integrative diagnosis and classification of myelodysplastic syndromes Not useful	Practical approach to the integrative diagnosis and classification of myelodysplastic syndromes Undecided/DNA
Practical approach to the integrative diagnosis and classification of myeloproliferative neoplasms	Practical approach to the integrative diagnosis and classification of myeloproliferative neoplasms Extremely useful	Practical approach to the integrative diagnosis and classification of myeloproliferative neoplasms Useful	Practical approach to the integrative diagnosis and classification of myeloproliferative neoplasms Fairly useful	Practical approach to the integrative diagnosis and classification of myeloproliferative neoplasms Not useful	Practical approach to the integrative diagnosis and classification of myeloproliferative neoplasms Undecided/DNA
Practical approach to The Who classification of acute leukemias	Practical approach to The Who classification of acute leukemias Extremely useful	Practical approach to The Who classification of acute leukemias Useful	Practical approach to The Who classification of acute leukemias Fairly useful	Practical approach to The Who classification of acute leukemias Not useful	Practical approach to The Who classification of acute leukemias Undecided/DNA
Cytogenetics and molecular pathology of acute myeloid leukemia	Cytogenetics and molecular pathology of acute myeloid leukemia Extremely useful	Cytogenetics and molecular pathology of acute myeloid leukemia Useful	Cytogenetics and molecular pathology of acute myeloid leukemia Fairly useful	Cytogenetics and molecular pathology of acute myeloid leukemia Not useful	Cytogenetics and molecular pathology of acute myeloid leukemia Undecided/DNA
Flow cytometry in the diagnosis of acute myeloid leukemia	Flow cytometry in the diagnosis of acute myeloid leukemia Extremely useful	Flow cytometry in the diagnosis of acute myeloid leukemia Useful	Flow cytometry in the diagnosis of acute myeloid leukemia Fairly useful	Flow cytometry in the diagnosis of acute myeloid leukemia Not useful	Flow cytometry in the diagnosis of acute myeloid leukemia Undecided/DNA
Integrative classification of acute leukemia (impact of morphology, flow cytometry and genetics)	Integrative classification of acute leukemia (impact of morphology, flow cytometry and genetics) Extremely useful	Integrative classification of acute leukemia (impact of morphology, flow cytometry and genetics) Useful	Integrative classification of acute leukemia (impact of morphology, flow cytometry and genetics) Fairly useful	Integrative classification of acute leukemia (impact of morphology, flow cytometry and genetics) Not useful	Integrative classification of acute leukemia (impact of morphology, flow cytometry and genetics) Undecided/DNA
Leukemias of ambiguous lineage	Leukemias of ambiguous lineage Extremely useful	Leukemias of ambiguous lineage Useful	Leukemias of ambiguous lineage Fairly useful	Leukemias of ambiguous lineage Not useful	Leukemias of ambiguous lineage Undecided/DNA
Minimal residual disease in acute myeloid leukemia by flow cytometry and molecular methods	Minimal residual disease in acute myeloid leukemia by flow cytometry and molecular methods Extremely useful	Minimal residual disease in acute myeloid leukemia by flow cytometry and molecular methods Useful	Minimal residual disease in acute myeloid leukemia by flow cytometry and molecular methods Fairly useful	Minimal residual disease in acute myeloid leukemia by flow cytometry and molecular methods Not useful	Minimal residual disease in acute myeloid leukemia by flow cytometry and molecular methods Undecided/DNA
How I follow up patients with acute myeloid leukemia	How I follow up patients with acute myeloid leukemia Extremely useful	How I follow up patients with acute myeloid leukemia Useful	How I follow up patients with acute myeloid leukemia Fairly useful	How I follow up patients with acute myeloid leukemia Not useful	How I follow up patients with acute myeloid leukemia Undecided/DNA
Key note lecture: Molecular pathology of myelodysplastic syndromes	Key note lecture: Molecular pathology of myelodysplastic syndromes Extremely useful	Key note lecture: Molecular pathology of myelodysplastic syndromes Useful	Key note lecture: Molecular pathology of myelodysplastic syndromes Fairly useful	Key note lecture: Molecular pathology of myelodysplastic syndromes Not useful	Key note lecture: Molecular pathology of myelodysplastic syndromes Undecided/DNA
Relevance of flow cytometry for the diagnosis of myelodysplastic syndromes	Relevance of flow cytometry for the diagnosis of myelodysplastic syndromes Extremely useful	Relevance of flow cytometry for the diagnosis of myelodysplastic syndromes Useful	Relevance of flow cytometry for the diagnosis of myelodysplastic syndromes Fairly useful	Relevance of flow cytometry for the diagnosis of myelodysplastic syndromes Not useful	Relevance of flow cytometry for the diagnosis of myelodysplastic syndromes Undecided/DNA
Integrative approach for the diagnosis and classification of myelodysplastic syndromes and therapy-related myeloid neoplasms (impact of morphology, flow cytometry and genetics)	Integrative approach for the diagnosis and classification of myelodysplastic syndromes and therapy-related myeloid neoplasms (impact of morphology, flow cytometry and genetics) Extremely useful	Integrative approach for the diagnosis and classification of myelodysplastic syndromes and therapy-related myeloid neoplasms (impact of morphology, flow cytometry and genetics) Useful	Integrative approach for the diagnosis and classification of myelodysplastic syndromes and therapy-related myeloid neoplasms (impact of morphology, flow cytometry and genetics) Fairly useful	Integrative approach for the diagnosis and classification of myelodysplastic syndromes and therapy-related myeloid neoplasms (impact of morphology, flow cytometry and genetics) Not useful	Integrative approach for the diagnosis and classification of myelodysplastic syndromes and therapy-related myeloid neoplasms (impact of morphology, flow cytometry and genetics) Undecided/DNA
Workshop 1: Diagnostically challenging AML cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO	Workshop 1: Diagnostically challenging AML cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Extremely useful	Workshop 1: Diagnostically challenging AML cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Useful	Workshop 1: Diagnostically challenging AML cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Fairly useful	Workshop 1: Diagnostically challenging AML cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Not useful	Workshop 1: Diagnostically challenging AML cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Undecided/DNA
Integrative approach for the diagnosis of myeloproliferative neoplasms	Integrative approach for the diagnosis of myeloproliferative neoplasms Extremely useful	Integrative approach for the diagnosis of myeloproliferative neoplasms Useful	Integrative approach for the diagnosis of myeloproliferative neoplasms Fairly useful	Integrative approach for the diagnosis of myeloproliferative neoplasms Not useful	Integrative approach for the diagnosis of myeloproliferative neoplasms Undecided/DNA
Integrative approach for the diagnosis of myelodysplastic/myeloproliferative neoplasms	Integrative approach for the diagnosis of myelodysplastic/myeloproliferative neoplasms Extremely useful	Integrative approach for the diagnosis of myelodysplastic/myeloproliferative neoplasms Useful	Integrative approach for the diagnosis of myelodysplastic/myeloproliferative neoplasms Fairly useful	Integrative approach for the diagnosis of myelodysplastic/myeloproliferative neoplasms Not useful	Integrative approach for the diagnosis of myelodysplastic/myeloproliferative neoplasms Undecided/DNA
Integrative approach for the diagnosis of myeloid diseases with eosinophilia	Integrative approach for the diagnosis of myeloid diseases with eosinophilia Extremely useful	Integrative approach for the diagnosis of myeloid diseases with eosinophilia Useful	Integrative approach for the diagnosis of myeloid diseases with eosinophilia Fairly useful	Integrative approach for the diagnosis of myeloid diseases with eosinophilia Not useful	Integrative approach for the diagnosis of myeloid diseases with eosinophilia Undecided/DNA
How to use integrative diagnostics of myelodysplastic syndrome in clinical practice	How to use integrative diagnostics of myelodysplastic syndrome in clinical practice Extremely useful	How to use integrative diagnostics of myelodysplastic syndrome in clinical practice Useful	How to use integrative diagnostics of myelodysplastic syndrome in clinical practice Fairly useful	How to use integrative diagnostics of myelodysplastic syndrome in clinical practice Not useful	How to use integrative diagnostics of myelodysplastic syndrome in clinical practice Undecided/DNA
Key note lecture: Genomic Medicine Sweden	Key note lecture: Genomic Medicine Sweden Extremely useful	Key note lecture: Genomic Medicine Sweden Useful	Key note lecture: Genomic Medicine Sweden Fairly useful	Key note lecture: Genomic Medicine Sweden Not useful	Key note lecture: Genomic Medicine Sweden Undecided/DNA
Relevance of molecular studies including antigen receptor rearrangement analysis for the diagnosis of T-lymphoproliferative disorders in the bone marrow	Relevance of molecular studies including antigen receptor rearrangement analysis for the diagnosis of T-lymphoproliferative disorders in the bone marrow Extremely useful	Relevance of molecular studies including antigen receptor rearrangement analysis for the diagnosis of T-lymphoproliferative disorders in the bone marrow Useful	Relevance of molecular studies including antigen receptor rearrangement analysis for the diagnosis of T-lymphoproliferative disorders in the bone marrow Fairly useful	Relevance of molecular studies including antigen receptor rearrangement analysis for the diagnosis of T-lymphoproliferative disorders in the bone marrow Not useful	Relevance of molecular studies including antigen receptor rearrangement analysis for the diagnosis of T-lymphoproliferative disorders in the bone marrow Undecided/DNA
Reactive T-cell proliferations in the bone marrow including those associated with myelodysplastic syndromes	Reactive T-cell proliferations in the bone marrow including those associated with myelodysplastic syndromes Extremely useful	Reactive T-cell proliferations in the bone marrow including those associated with myelodysplastic syndromes Useful	Reactive T-cell proliferations in the bone marrow including those associated with myelodysplastic syndromes Fairly useful	Reactive T-cell proliferations in the bone marrow including those associated with myelodysplastic syndromes Not useful	Reactive T-cell proliferations in the bone marrow including those associated with myelodysplastic syndromes Undecided/DNA
Integrative approach to distinguish T-LGL from non-neoplastic T-LGL proliferations	Integrative approach to distinguish T-LGL from non-neoplastic T-LGL proliferations Extremely useful	Integrative approach to distinguish T-LGL from non-neoplastic T-LGL proliferations Useful	Integrative approach to distinguish T-LGL from non-neoplastic T-LGL proliferations Fairly useful	Integrative approach to distinguish T-LGL from non-neoplastic T-LGL proliferations Not useful	Integrative approach to distinguish T-LGL from non-neoplastic T-LGL proliferations Undecided/DNA
Update on T-prolymphocytic Leukemia, Hepatosplenic T-cell lymphoma and Adult T-cell leukemia/lymphome	Update on T-prolymphocytic Leukemia, Hepatosplenic T-cell lymphoma and Adult T-cell leukemia/lymphome Extremely useful	Update on T-prolymphocytic Leukemia, Hepatosplenic T-cell lymphoma and Adult T-cell leukemia/lymphome Useful	Update on T-prolymphocytic Leukemia, Hepatosplenic T-cell lymphoma and Adult T-cell leukemia/lymphome Fairly useful	Update on T-prolymphocytic Leukemia, Hepatosplenic T-cell lymphoma and Adult T-cell leukemia/lymphome Not useful	Update on T-prolymphocytic Leukemia, Hepatosplenic T-cell lymphoma and Adult T-cell leukemia/lymphome Undecided/DNA
How to perform bone marrow diagnostics with limited resources	How to perform bone marrow diagnostics with limited resources Extremely useful	How to perform bone marrow diagnostics with limited resources Useful	How to perform bone marrow diagnostics with limited resources Fairly useful	How to perform bone marrow diagnostics with limited resources Not useful	How to perform bone marrow diagnostics with limited resources Undecided/DNA
Workshop 2: Diagnostically challenging MDS cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO	Workshop 2: Diagnostically challenging MDS cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Extremely useful	Workshop 2: Diagnostically challenging MDS cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Useful	Workshop 2: Diagnostically challenging MDS cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Fairly useful	Workshop 2: Diagnostically challenging MDS cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Not useful	Workshop 2: Diagnostically challenging MDS cases with focus on integration of clinical, morphological, phenotypical and molecular data according to WHO Undecided/DNA
Update on NK-cell leukemias and EBV-positive T- and NK-cell lymphoproliferative diseases of childhood	Update on NK-cell leukemias and EBV-positive T- and NK-cell lymphoproliferative diseases of childhood Extremely useful	Update on NK-cell leukemias and EBV-positive T- and NK-cell lymphoproliferative diseases of childhood Useful	Update on NK-cell leukemias and EBV-positive T- and NK-cell lymphoproliferative diseases of childhood Fairly useful	Update on NK-cell leukemias and EBV-positive T- and NK-cell lymphoproliferative diseases of childhood Not useful	Update on NK-cell leukemias and EBV-positive T- and NK-cell lymphoproliferative diseases of childhood Undecided/DNA
Update of Posttransplant- and Immunodeficiency-associated Lymphoproliferative disorders in the bone marrow	Update of Posttransplant- and Immunodeficiency-associated Lymphoproliferative disorders in the bone marrow Extremely useful	Update of Posttransplant- and Immunodeficiency-associated Lymphoproliferative disorders in the bone marrow Useful	Update of Posttransplant- and Immunodeficiency-associated Lymphoproliferative disorders in the bone marrow Fairly useful	Update of Posttransplant- and Immunodeficiency-associated Lymphoproliferative disorders in the bone marrow Not useful	Update of Posttransplant- and Immunodeficiency-associated Lymphoproliferative disorders in the bone marrow Undecided/DNA
Workshop 3: Neoplastic and ambiguous T-cell profile rations in the bone marrow	Workshop 3: Neoplastic and ambiguous T-cell profile rations in the bone marrow Extremely useful	Workshop 3: Neoplastic and ambiguous T-cell profile rations in the bone marrow Useful	Workshop 3: Neoplastic and ambiguous T-cell profile rations in the bone marrow Fairly useful	Workshop 3: Neoplastic and ambiguous T-cell profile rations in the bone marrow Not useful	Workshop 3: Neoplastic and ambiguous T-cell profile rations in the bone marrow Undecided/DNA

Question Title

* 6. Was there adequate time available for discussions, questions & answers and learner engagement?

Yes, always/almost always

Yes, sometimes

Only rarely

Never

Undecided

Can you indicate any innovative elements during the activity?

Question Title

* 7. Will the information you learnt be implemented in your practice?

Very much

Somewhat

Not much

Not at all

Undecided

Can you provide ONE example how this event will influence your future practice?

Question Title

* 8. Did all the faculty members provide their potential conflict of interest declaration with the sponsor(s) as a second slide of their presentation?

Yes, all

Yes, for the majority

Yes, but only a small part

Undecided/Don't know

Can you provide an example of biased presentation in this activity?

Question Title

* 9. Do you agree that the information was overall free of commercial and other bias?

Strongly agree

Rather agree

Rather disagree

Strongly disagree

Undecided/don't know

Question Title

* 10. To receive your CME certificate, please state your full name and email address.

Full name

Email address

Number of credits I'm entitled to